Evaluating the effect of Tabashir mucoadhesive paste on management of oral ulcers in rheumatic patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180114038356N4

Enrollment

Registered

2024-05-13

Start date

2024-07-13

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatic patients with oral ulcers. Rheumatism, unspecified

Interventions

Intervention 1: Intervention group: 25 Rheumatoid patients with oral ulcers receive the desired drug (Tebashir mucoadhesive paste, three times a day for 5 days). Intervention 2: Control group: 25 rheu

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with lupus suffer from oral ulcers Patients with Sjogren's suffer from oral ulcers Patients with Behcet's disease suffer from oral ulcers Patients with spondyloarthropathies suffer from oral ulcers

Exclusion criteria

Exclusion criteria: Patients with ulcers following chemotherapy Presence of oral candidiasis

Design outcomes

Primary

Measure	Time frame
Investigating the effect of Tabashir adhesive mucus paste on the healing of oral ulcers. Timepoint: Before intervention and 3, 5 days after intervention. Method of measurement: Questionnaires.	—

Secondary

Measure	Time frame
Intensity of pain. Timepoint: Before intervention and 3, 5 days after intervention. Method of measurement: Questionnaires: Numerical Pain Rating Scale(NPRS).;Degree and area of mouth ulcer. Timepoint: Before intervention and 3, 5 days after intervention. Method of measurement: Questionnaires: Pemphigus Oral Lesions Intensity Score (POLIS).;Evaluation of difficulties in speaking, eating normal foods and other foods based on hardness and softness. Timepoint: Before intervention and 3, 5 days after intervention. Method of measurement: Questionnaires based on Likert scale.;Size of oral lesions in terms of redness and inflammation. Timepoint: Before intervention and 3, 5 days after intervention. Method of measurement: ????? ?????(???? ?? ??????) ?? ?????? ?????? ????? ?? ?? ?????(?? ???? ??? ?????? ?? ?????? ? ?????? ????? ????? ???? ????? ??? ???? ?...) ?? ?? ????? ???? ????? ????? ????? ????? ??: ???: ????>40%? ????: 30-39%? ?????: 20-29%? ????: 10-19%? ????? ????: ?????? ???? ?? ???? ???? ?? 9% ???? ?? ?????? ?????? ????.	—

Measure

Time frame

Intensity of pain. Timepoint: Before intervention and 3, 5 days after intervention. Method of measurement: Questionnaires: Numerical Pain Rating Scale(NPRS).;Degree and area of mouth ulcer. Timepoint: Before intervention and 3, 5 days after intervention. Method of measurement: Questionnaires: Pemphigus Oral Lesions Intensity Score (POLIS).;Evaluation of difficulties in speaking, eating normal foods and other foods based on hardness and softness. Timepoint: Before intervention and 3, 5 days after intervention. Method of measurement: Questionnaires based on Likert scale.;Size of oral lesions in terms of redness and inflammation. Timepoint: Before intervention and 3, 5 days after intervention. Method of measurement: ????? ?????(???? ?? ??????) ?? ?????? ?????? ????? ?? ?? ?????(?? ???? ??? ?????? ?? ?????? ? ?????? ????? ????? ???? ????? ??? ???? ?...) ?? ?? ????? ???? ????? ????? ????? ????? ??: ???: ????>40%? ????: 30-39%? ?????: 20-29%? ????: 10-19%? ????? ????: ?????? ???? ?? ???? ???? ?? 9% ???? ?? ?????? ?????? ????.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomayyeh Karami-Mohajeri

Kerman University of Medical Sciences

somayyehkarami@gmail.com+98 34 3132 5001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026